bibliographicCitation |
Wang W, Wang L, Chang JY, Hu F, Yan JY, Zhang J, Liang YP, Zhang HW, Wu HP, Cai HF. Cardiotoxicity monitoring of pyrotinib in combination with nab-paclitaxel, doxorubicin, and cyclophosphamide in HER2-positive breast cancer: a single-armed clinical trial. Gland Surg. 2022 Apr;11(4):742–50. PMID: 35531104; PMCID: PMC9068533. |